COT/COM/COC Annual Report 2022
Guidance statements - COC 2022
In this guide
In this guide3.20 The Committee continued development of the guidance statement series during 2022. Final revisions to the COC Guidance Statement (G04) ‘Use of Biomarkers in Carcinogenic Risk Assessment’ are ongoing and are expected to be completed in 2023.